Pharmacotherapy for obesity
نویسندگان
چکیده
منابع مشابه
Pharmacotherapy for Obesity
BACKGROUND Obesity is a serious, chronic, relapsing disease of energy regulation, with strong genetic and early-life environmental determinants. Pharmacotherapy can be a useful adjunct to lifestyle intervention in effecting and maintaining clinically meaningful weight loss. OBJECTIVE The aim of this article is to discuss the role of pharmacotherapy in obesity management. The efficacy, side ef...
متن کاملSizing up pharmacotherapy for obesity.
Part of the Medical Pharmacology Commons, and the Pharmacy and Pharmaceutical Sciences Commons This Article is brought to you for free and open access by the Jefferson Digital Commons. The Jefferson Digital Commons is a service of Thomas Jefferson University's Center for Teaching and Learning (CTL). The Commons is a showcase for Jefferson books and journals, peer-reviewed scholarly publications...
متن کاملPharmacotherapy of obesity
10.2217/14750708.5.2.223 © 2 Obesity is a major health problem with significant comorbidities. Its prevalence has dramatically increased over the last few decades, so that it is considered an international epidemic. Large epidemiologic studies have clearly associated obesity with cardiovascular disease and side effects in almost every organ system, so that the need for treatment appears to be i...
متن کاملObesity pharmacotherapy: current status.
Obesity is a medical condition in which excess body fat has accumulated to such an extent that it may have an adverse effect on health, leading to reduced life expectancy (Haslam and James, 2005). The lifestyle treatments directed at improving diet and physical activity are considered as first line treatment for obesity; however, if these fail, antiobesity medication is recommended. In the past...
متن کاملPharmacotherapy for obesity--promise and uncertainty.
In 2005, a majority of adult Americans are overweight or obese,1 putting millions of them at increased risk for serious medical conditions, including cardiovascular disease, type 2 diabetes mellitus, and certain forms of cancer. In obesity, a weight loss of 5 to 10 percent can significantly improve risk factors for obesity-related diseases2 and delay or prevent type 2 diabetes in persons at hig...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: British Journal of Clinical Pharmacology
سال: 2009
ISSN: 0306-5251,1365-2125
DOI: 10.1111/j.1365-2125.2009.03453.x